Alyvant uses de-identified patient-level analytics to better understand the nuances of a disease, patterns of physician prescribing, and payer reimbursement. We then turn insights into action through our fit-for-purpose commercial pharmaceutical organization. Our long-range vision is to use technology to reduce the cost of commercializing all medicines, thereby generating savings for the healthcare system at large and helping to ensure that every patient who might benefit from an approved therapy has the opportunity to speak with a physician about appropriate treatment options.
View Top Employees from Alyvant, Inc.Website | http://www.alyvant.com/ |
Revenue | $3 million |
Employees | 29 (4 on RocketReach) |
Founded | 2018 |
Address | 135 5th Ave 4th floor, New York, New York 10010, US |
Phone | (646) 767-5878 |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Pharmaceuticals, Manufacturing, Commercialization, Technology, Sales Force Optimization, Co-Promotion, Digital Deployment, Agile Commercial Platform, Patient Finding, Physician Activation |
Competitors | Acura Pharmaceuticals, Inc, AdhereTech, CET Pharmacy Group |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Alyvant, Inc. employee's phone or email?
The Alyvant, Inc. annual revenue was $3 million in 2024.
4 people are employed at Alyvant, Inc..
Alyvant, Inc. is based in New York, New York.
The NAICS codes for Alyvant, Inc. are [3254, 32541, 32, 325].
The SIC codes for Alyvant, Inc. are [28, 283].